Kardigan, Inc.

NASDAQ:KARD

Biotechnology

Healthcare
$12.32 +3.50%

+$0.77 today

Market cap
$1.10B
Beta
0.00
52W Low $16.25High $24.00

Volume 0.55M

Average 5.84M

KARD Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

No reported Net Receivables figures are available to summarize.

Net Receivables history

Currency unavailable · from the balance sheet

No Net Receivables data reported for this period type.

Net Receivables vs competitors

How KARD compares with its peers on the latest reported figures

KARD Competitors
Net Receivables for KARD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CYTKCytokinetics, IncorporatedJun 2026$24.43M USD+190.5%+394.4%1.3%
NAMSNewAmsterdam Pharma Company N.V.Jun 2026$24M USD——3.4%
RNAAtrium Therapeutics, Inc.Mar 2026$15M USD——5.1%
TNYATenaya Therapeutics, Inc.Mar 2026$10.63M USD——7.9%
IKTInhibikase Therapeutics, Inc.Mar 2026$0 USD——0.0%
KARDKardigan, Inc.—— ———
Peer median (excluding KARD) —+190.5%+394.4%3.4%

Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kardigan, Inc.

NASDAQ:KARD

Intrinsic Alpha fair value

Locked

Current Price

$12.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.